❔ Want to learn more about immunotherapy in the frail, elderly 🧓 or immunocompromised 🌡️ population? 👉 Register for the webinar on November 29th. msdconnect.be/nl/webinars/we…

What’s the prognostic meaning of irAEs in MSI CRC? 🤔 Not all irAEs are the same! 📈 ⬆️ outcomes if musculoskeletal and endocrine 🟢 BUT 📉 ⬇️prognosis if liver, GI, neuro and lung AEs 🔴 Check out our work, led by Filippo Pietrantonio #CRCsm #immunotherapy jitc.bmj.com/content/11/1/e…

New Year's 🎉 resolution number 1⃣: improve! 👉 Let us know what you think of Belgian ImmunoToxicity board via our survey: vub.fra1.qualtrics.com/jfe/form/SV_dn…

Immunotox poster by UZ Brussel PhD student Marthe Verhaert #BSMO2023

Eat your greens! 🥦

📄 Just published: a successful treatment of steroid-dependent ICI-induced pericarditis ❤️‍🩹 with azathioprine 💊 👉 doi.org/10.1093/ehjcr/… EHJ Editor-in-Chief Marthe Verhaert Sandrine Aspeslagh Berlinde von Kemp #irAE #multidisciplinary #pericarditis

🔉 Recurrent? Resistant? Refractory? Let's speak the same #language! 📄 Interesting and necessary Society for Immunotherapy of Cancer consensus definitions for #irAE terminology. Read it here 👇 💪 Jarushka Naidoo Dr. Julie Brahmer Elad Sharon @cappelliMD

📌 Launching in June: the #HCC podcast expert series 🎙 Using #podcasts to keep physicians informed on the newest insights in HCC treatment, with #ICI as new kids on the block 🏥 ⏩ A great initiative to improve information dissemination and thus #safety of treatment!

The more you know! 🎙️

"Scientists searching for insights are increasingly convinced that changes to nutrition and ways of living that began in the middle of the last century hold at least part of the key to the puzzle." ft.com/content/90d5f2…

One of the motivations we developed the #FORX trial to investigate how 🥦🍐🍏🍒🥕 can improve #immunotherapy outcome. All support 🪙 is welcome to start our study asap act.uzbrusselfoundation.be/nl-NL/project/…

Standing room only in the climate sustainability session showing how important this topic is to the oncology community ESMO - Eur. Oncology OncoAlert

Come see what our PhD student is up to ESMO - Eur. Oncology in Hall 8 #forx

Part of UZ Brussel Medical Oncology participating in the #bsmoxmas 🎄 sweater challenge. Happy and safe holidays to all! Belgian Society of Medical Oncology

This March, our Belgian Society of Medical Oncology Belgian ImmunoToxicity board 🇧🇪 ImmunoToxicity board exists 3 years and has discussed over 260 #irAE or #dysimmunity cases!🥳 Want to #join or share #feedback? Head to 🌐 bsmo.be/bitox or 📩 [email protected]!

Our very own Sandrine Aspeslagh presenting 3 years of #bitox at the #iTOX symposium of Gustave Roussy 🎂

📰 European Journal of Cancer just #published my #review on what patients can influence themselves when starting #immunotherapy. I summarize the evidence behind 🍽 , 💊 and 👟, highlighting patient #empowerment. ➡️doi.org/10.1016/j.ejca…

Happy that our #network was lauded last weekend 🥇—a testament to how, despite our often #perfectionist doctor mindset, we embrace #collaboration to find the best solutions for our patients #together.

We exist 4 years! 🎉 How can we #improve? 📬 Let's hear your #feedback via this quick survey: vub.fra1.qualtrics.com/jfe/form/SV_0I…

Get to know 2025 SITC At-Large Director candidate Aurélien Marabelle, MD, PhD (Gustave Roussy). Read Dr. Marabelle’s bio and position statement: sitcancer.org/get-involved/2…